This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May 28, 2014


 

Advertisement

Chemoresistance decreased in ovarian cancer
Oncology Nurse Advisor
Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in patients with ovarian cancer, according to researchers. Two enzymes have been identified that suppress proteins important for regulating cell survival and chemoresistance in ovarian cancer.  Ovarian cancer is one of the deadliest gynecological cancers, with a 60 percent mortality rate and a five-year survival rate for less than 30 percent of women in the advanced stage of the disease.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the US
Cancer Research
Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the average annual percentage changes in incidence and death rates. Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, respectively.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Congratulations to the four-time recipients of the OAA Award
Commission on Cancer
The Commission on Cancer, a quality program of the American College of Surgeons, announced the recipients of the 2013 Outstanding Achievement Award (OAA) earlier this month. Of the 74 OAA recipients, the following programs have achieved this level of distinction for four accreditation cycles (2004, 2007, 2010, and 2013): Audrain Medical Center, Mexico, MO; George Washington University Hospital, Washington, DC; Good Samaritan Hospital, San Jose, CA; Naval Medical Center San Diego, San Diego, CA; Northside Hospital, Atlanta, GA; PIH Health – Whittier, Whittier, CA; ProHealth Care, Inc., Waukesha, WI; Regional West Medical Center, Scottsbluff, NE; Southwestern Regional Medical Center, Tulsa, OK; and Virtua Health, Marlton, NJ.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Prostate cancer 'could be transmitted sexually'
WebMD
Prostate cancer might be a sexually transmitted disease caused by a common infection, according to a study. Experts say the research has limitations and is not proof, though. Scientists at the University of California found evidence of a link between prostate cancer and the STD trichomoniasis, in which a common parasite is passed on during unprotected sexual contact.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Obamacare lightens load for cancer patients
Chicago Tribune
Fiona O'Connell is familiar with the working person's health care nightmare — the one where you get too sick to work, and then you lose your job, and then you have no insurance to pay for the treatment you need. O'Connell lived that nightmare, and she's still bitter and angry. But now she can talk about it in the past tense. As of Jan. 1, the cancer survivor has medical insurance under the Affordable Care Act.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Register now — Strengthening Your Cancer Program...Utilizing the Rapid Quality Reporting System to Comply with the New Commendation Standard
Commission on Cancer
Strengthening Your Cancer Program...Utilizing the Rapid Quality Reporting System to Comply with the New Commendation Standard will be held on June 18 in Chicago, the day before the 2014 CoC Workshop. This workshop will provide important information to help your program comply with the new commendation standard that requires programs, from initial enrollment and throughout the three-year accreditation period, to participate in the Rapid Quality Reporting System (RQRS). Register now for the program; registration fees are $250 if registration is received on or before May 15 and $300 if registration is received after May 15, 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Biomarker holds promise for esophageal cancer
Oncology Nurse Advisor
A new biomarker for esophageal cancer shows promise in improving screening for this deadly disease and its precursor, Barrett esophagus. These findings were presented at Digestive Disease Week in Chicago. Amitabh Chak, MD, of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine in Cleveland, Ohio, and a research team found that a change in the DNA, methylation of the vimentin gene, can be an effective new less-invasive test for detecting Barrett esophagus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Coming soon — Learning the Basics of CoC Accreditation Workshop
Commission on Cancer
The first program, held early this year, was a sell-out. To meet the numerous requests, the Commission on Cancer (CoC) will repeat Learning the Basics of CoC Accreditation on September 12, 2014, in San Antonio, Texas. Plan now to attend the only program developed by the professionals who are involved in CoC standards development and the survey process. Watch your e-mail for detailed information or contact srubin@facs.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Pancreatic cancer may become number two cause of cancer deaths
Fox News
Pancreatic cancer is projected to become the second most common cause of cancer-related death in the United States in 2030, overtaking deaths from breast and colon cancers, according to new research. Currently, the top three causes of cancer-related death in the United States are lung, colorectal and breast cancers. Pancreatic cancer is fourth, followed by prostate and liver cancers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Register now for the 2014 CoC workshop — Strengthening Your Cancer Program...Enriching the Coordinators' Role
Commission on Cancer
On June 19-20 in Chicago, the Commission on Cancer (CoC) will hold a new workshop entitled Strengthening Your Cancer Program…Enriching the Coordinators' Role. This program provides information and case studies on the roles and responsibilities of the various CoC-designated coordinators. The two-day program will cover what the various coordinators' roles are, what their roles on the cancer committee involve, and how to meet and improve the required responsibilities based on the CoC Standards. Register for the program. Program fees are $650 if registration is received on or before May 15 and $750 if registration is received after May 15.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advances in melanoma treatment prolonging lives
The Boston Globe
Richard Murphy is both the unluckiest and luckiest of men. The former hotel and restaurant owner was unlucky when he developed an unusual type of a rare skin cancer that strikes only about 500 Americans a year. By the time doctors caught it, it had spread beyond the tumor in his nose. When Murphy, who lives in Marshfield, Massachusetts, was diagnosed, doctors had only three treatments to choose from for stage 4 melanomas like his, none of which had been shown to extend lives. Only four in 25 patients survived five years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


70 percent of masectomies aren't necessary — Here's why women have them anyway
TIME
In a new study published in JAMA Surgery, researchers say that 70 percent of women with breast cancer in one breast who decide to remove the other breast do so unnecessarily. In fact, only 10 percent of women diagnosed with breast cancer should consider such prophylactic mastectomy, say experts.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FORDS revision project
Commission on Cancer, National Cancer Data Base
FORDS is a manual that contains all of the data items with rules and coding options for cancer registrars to collect data in their hospital registry. These data are then submitted to the National Cancer Data Base (NCDB). The data available in the NCDB come from FORDS, Collaborative Stage, and the AJCC Cancer Staging Manual. The Commission on Cancer (CoC) is seeking input from registrars, data users, physicians, and others to modernize the current FORDS manual. This project kicked off in April 2014. The input will be gathered through an electronic survey, which will be open through September 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


9 simple questions that may predict your heart disease or cancer risk
Today
Primary care physicians could save lives by asking patients nine simple questions, a new study suggests. By asking a series of family-related questions as part of routine care, doctors are more likely to catch patients who have inherited a higher risk for developing certain cancers, heart disease, and diabetes, Australian researchers note in a report published in the Annals of Family Medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


National Cancer Survivors Day
Commission on Cancer
June 1 marks the 27th Annual National Cancer Survivors Day that brings cancer survivors together to show that there is life after receiving a diagnosis of cancer. The Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC) encourage your center to observe this day and use it as an opportunity to display/promote your CoC and/or NAPBC accreditation status. To help you promote this event within your program and the community, the CoC and the NAPBC have developed a poster that you can download and print. To access the poster, CoC-accredited programs can go to CoC Datalinks and click on the “Marketing Resources”; NAPBC-accredited centers can log into the NAPBC Portal and click “Marketing Page” under the Marketing Resources tab. For information, please contact Susan Rubin.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
 
Advertisement

Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 21, 2014
May 14, 2014
May 7, 2014
April 30, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063